This page defines the modelling rules and description templates for Phase 1 only of the Canadian Medicines Terminology (CMT) project. Phase-specific content will be added as the project progresses.
An abstract representation of a medicinal product, based on a description of only and exclusively the active ingredient(s) it contains and its dose form. The active ingredients used to define a VMPF do not include any modification that is not either clinically significant or (if relevant) part of the product’s basis of strength substance.
The VMPF uses the following defining attributes:
Attribute | Alias | Group | Card | G Card | D/O | Range |
373873005 |Count of base of active ingredient| | BCount | NO | 1..1 | 0..0 | DATA | Integer >#0.. |
127489000 |Has active ingredient| | AI | YES | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
762949000 |Has precise active ingredient | PAI | YES | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
732943007 |Has basis of strength substance| | BOSS | YES | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
411116001|Has manufactured dose form| | MDF | NO | 0..1 | 0..0 | OBJECT | < 736542009 |Pharmaceutical dose form| |
Up to two VMPF concepts are created for each DPD drug product. These are listed below
The first VMPF concept must always be created (unless it already exists) for every DPD drug product and is defined using the following attributes:
Attribute | Alias | Group | Card | G Card | D/O | Range |
373873005 |Count of base of active ingredient| | BCount | NO | 1..1 | 0..0 | DATA | Integer >#0.. |
127489000 |Has active ingredient| | AI | YES | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
411116001|Has manufactured dose form| | MDF | NO | 0..1 | 0..0 | OBJECT | < 774167006 |Product name| |
The second VMPF concept will only be created (unless it already exists) for each DPD drug product when:
BCount = 1 AND [0..0] TCD.BMCount (i.e. does not exist) AND BOSS <> AI
(i.e. single ingredient and BOSS <> AI)
and is defined using the following attributes:
Attribute | Alias | Group | Card | G Card | D/O | Range |
373873005 |Count of base of active ingredient| | BCount | NO | 1..1 | 0..0 | DATA | Integer >#0.. |
762949000 |Has precise active ingredient | PAI | YES | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
732943007 |Has basis of strength substance| | BOSS | YES | 0..* | 0..1 | OBJECT | < 105590001 |Substance| |
411116001|Has manufactured dose form| | MDF | NO | 0..1 | 0..0 | OBJECT | < 774167006 |Product name| |
Format
VMPF-1 (mandatory)
“Product containing only” [[ + @AI]] “ ” [[ + @MDF ]] “ (medicinal product form)” 1
VMPF-2 (optional)
“Product containing precisely ” [[ + @PAI 3 OR @BOSS 4]] [ “ (as ” [[ + @PAI ]] “)”] 4“ ” [[ + @MDF ]] “ (medicinal product form)” 1
Format
VMPF-1 (mandatory)
[[ + @AI]] 2
VMPF-2 (optional)
[[ + @PAI 3 OR @BOSS 4]] [ “ (” [[ + @PAI ]] “)”] 4,2
1: For all attribute values, use the en-CA FSN with no semantic tag
2: For all attribute values, use the en-CA PT
3: PAI is used here when:
4: “BOSS (as PAI)” is used here when:
Format
VMPF-1 (mandatory)
“produit contenant seulement” [[ + @AI]] “ ” [[ + @MDF ]] “ (forme du produit médicinal)”1
VMPF-2 (optional)
“produit contenant précisément” [[ + @PAI 3 OR @BOSS 4]] [ “ (” [[ + @PAI ]] “)”] 4“ ” [[ + @MDF ]] “ (forme du produit médicinal)” 1
Format
VMPF-1 (mandatory)
[[ + @AI]] 2
VMPF-2 (optional)
[[ + @PAI 3 OR @BOSS 4]] [ “ (” [[ + @PAI ]] “)”] 4,2
1: For all attribute values, use the fr-CA FSN with no semantic tag
2: For all attribute values, use the fr-CA PT
3: PAI is used here when:
4: “BOSS (as PAI)” is used here when:
VMPF-1
VMPF-2